|
Respiratory or allergic morbidities
|
Age 0–1
|
Age 2–3
|
Age 4–5
|
Age 6–7
|
Age 8–9
|
Age 10–11
|
Age 12–13
|
Age 14–15
|
|---|
|
OR (95% CI)
|
OR (95% CI)
|
OR (95% CI)
|
OR (95% CI)
|
OR (95% CI)
|
OR (95% CI)
|
OR (95% CI)
|
OR (95% CI)
|
|---|
|
N = 4977
|
N = 4485
|
N = 4264
|
N = 4088
|
N = 3922
|
N = 3574
|
N = 3097
|
N = 2960
|
|---|
|
Wheezing
|
|
All children
|
|
Wheezing = Yes
|
1.49 (1.13–1.97)*
|
1.83 (1.4–2.4)**
|
1.47 (1.08–1.99)Ϯ
|
1.8 (1.3–2.49)**
|
1.91 (1.34–2.71)**
|
2.47 (1.69–3.61)**
|
1.69 (1.02–2.78)Ϯ
|
1.27 (0.72–2.24)
|
|
Wheezing = No (ref.)
| | | | | | | | |
|
Male only
|
|
Wheezing = Yes
|
1.5(1.03–2.18)Ϯ
|
1.93(1.34–2.76)**
|
1.77(1.20–2.63)*
|
2.07(1.35–3.18)**
|
1.97(1.22–3.17)*
|
3.28(2.01–5.34)**
|
1.56(0.78–3.11)
|
1.13(0.49–2.61)
|
|
Wheezing = No (ref.)
| | | | | | | | |
|
Female only
|
|
Wheezing = Yes
|
1.46(0.94–2.24)
|
1.73(1.14–2.65)*
|
1.15(0.70–1.91)
|
1.59(0.96–2.66)
|
1.8(1.03–3.15)Ϯ
|
1.72(0.92–3.21)
|
1.67 (0.81–3.46)
|
1.47 (0.69–3.15)
|
|
Wheezing = No (ref.)
| | | | | | | | |
|
Ever diagnosed asthma
|
|
All children
|
|
Ever had asthma = Yes
| |
2.22 (1.65–3)**
|
2.34 (1.77–3.10)**
|
2.58 (1.94–3.44)**
|
2.42 (1.83–3.20)**
|
2.64 (1.96–3.56)**
|
2.9 (2.09–4.02)**
|
2.5 (1.78–3.52)**
|
|
Ever had asthma = No (ref.)
| | | | | | | |
|
Male only
|
|
Ever had asthma = Yes
| |
2.76(1.86–4.11)**
|
2.75(1.86–4.07)**
|
2.69(1.81–3.98)**
|
2.87(1.93–4.28)**
|
3.04(1.98–4.67)**
|
2.66(1.69–4.18)**
|
2.35(1.46–3.79)**
|
|
Ever had asthma = No (ref.)
| | | | | | | |
|
Female only
|
|
Ever had asthma = Yes
| |
1.77(1.10–2.86)Ϯ
|
2.01(1.30–3.10)*
|
2.44(1.57–3.81)**
|
1.98(1.30–3.01)**
|
2.29(1.46–3.59)**
|
3.42(2.06–5.69)**
|
2.83(1.73–4.62)**
|
|
Ever had asthma = No (ref.)
| | | | | | | |
|
Ongoing asthma
|
|
All children
|
|
Ongoing asthma = Yes
| |
2.53 (1.85–3.46)**
|
3.29 (2.47–4.40)**
|
3.32 (2.45–4.50)**
|
2.75 (2.03–3.73)**
|
3.74 (2.72–5.15)**
|
3.18 (2.22–4.56)**
|
2.63 (1.79–3.87)**
|
|
Ongoing asthma = No (ref.)
| | | | | | | |
|
Male only
|
|
Ongoing asthma = Yes
| |
3.17(2.10–4.77)**
|
4.09(2,76–6.08)**
|
3.30(2.17–5.00)**
|
2.74(1.79–4.20)**
|
3.66(2.36–5.68)**
|
3.17(1.93–5.21)
|
2.00(1.14–3.48)*
|
|
Ongoing asthma = No (ref.)
| | | | | | | |
|
Female only
|
|
Ongoing asthma = Yes
| |
2.08(1.27–3.41)*
|
2.68(1.69–4.24)**
|
3.40(2.14–5.39)**
|
2.83(1.81–4.43)**
|
4.09(2.55–6.56)**
|
3.38(1.94–5.86)**
|
3.30(1.88–5.82)**
|
|
Ongoing asthma = No (ref.)
| | | | | | | |
|
Eczema
|
|
All children
|
|
Eczema = Yes
|
1.43 (1.06–1.94)Ϯ
|
1.2 (0.88–1.63)
|
1.45 (1.04–2.04)Ϯ
|
1.97 (1.4–2.77)**
|
1.38 (0.95–1.99)
|
1.56 (1.04–2.35)Ϯ
|
1.71 (1.09–2.67)Ϯ
|
1.09 (2.67–0.018)
|
|
Eczema = No (ref.)
| | | | | | | | |
|
Male only
|
|
Eczema = Yes
|
1.46(0.96–2.21)Ϯ
|
1.13(0.73–1.75)
|
1.33(0.83–2.12)
|
2.08(1.29–3.36)*
|
1.76(1.05–2.96)Ϯ
|
2.18(1.24–3.84)*
|
1.16(0.58–2.34)
|
0.93(0.41–2.09)
|
|
Eczema = No (ref.)
| | | | | | | | |
|
Female only
|
|
Eczema = Yes
|
1.39(0.90–2.15)
|
1.28(0.82–2.01)
|
1.62(0.99–2.66)
|
1.88(1.15–3.07)
|
1.11(0.67–1.85)
|
1.03(0.58–1.83)
|
2.15(1.21–3.83)
|
1.95(1.08–3.51)
|
|
Eczema = No (ref.)
| | | | | | | | |
- Notes: Ϯ p < 0.05 & > 0.01, * p < 0.01 & > 0.001, ** p < 0.001, the regression models were adjusted for covariates outlined in ‘Control variables’ sub-section of ‘Methods’ section. Abbreviation: OR Odds Ratio; ref., reference category
